Denali Capital Acquisition Corp. Unit
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch DNQUF and buy or sell other stocks, ETFs, and their options commission-free!About DNQUF
Semnur Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company focused on developing and commercializing innovative non-opioid pain management products for the treatment of acute and chronic pain. Its lead product candidate, SP-102, is a non-opioid novel injectable corticosteroid gel formulation for patients with moderate to severe lumbosacral radicular pain.
CEOJaisim Shah, MBA
CEOJaisim Shah, MBA
Employees3
Employees3
HeadquartersPalo Alto, California
HeadquartersPalo Alto, California
Founded
Founded
Employees3
Employees3
DNQUF Key Statistics
Market cap2.99B
Market cap2.99B
Price-Earnings ratio-27.93
Price-Earnings ratio-27.93
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$12.99
52 Week high$12.99
52 Week low$10.42
52 Week low$10.42
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.